Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1950217 | Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2007 | 8 Pages |
The mechanism by which treatment of mice with CCl4 induces an increase in choline kinase α has been investigated. Nuclear run on assays demonstrated a major increase in the transcript for choline kinase α in livers from mice 3 h and 6 h after administration of CCl4 compared to vehicle (olive oil). 5′deletion analyses of choline kinase α promoter-luciferase constructs expressed in Hepa-1 cells identified a promoter element between − 875 and − 866 that was nearly identical to an AP-1 consensus site. Mutation of this AP-1 site caused a striking decrease in the expression of choline kinase α promoter-luciferase constructs. Electromobility shift assays with nuclear extracts from mouse liver demonstrated that c-Jun, but not c-fos, bound oligonucleotides with the AP-1 site. The amount of c-jun bound was greatly increased when hepatic nuclear extracts from mice treated with CCl4 were used. Chromatin immunoprecipitation assays confirmed that c-jun binds to the choline kinase α promoter. The results from these studies provide strong evidence that the choline kinase α promoter has a distal element (− 875/− 867) that binds c-jun and the binding of c-jun is enhanced by treatment with CCl4.